Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/114151
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorSchool of Optometry-
dc.creatorZhang, X-
dc.creatorWang, S-
dc.creatorHuang, Y-
dc.creatorXie, Y-
dc.creatorSeth, I-
dc.creatorBulloch, G-
dc.creatorLai, C-
dc.creatorHu, Y-
dc.creatorShang, X-
dc.creatorHe, M-
dc.creatorZhu, Z-
dc.creatorYu, H-
dc.date.accessioned2025-07-15T08:41:54Z-
dc.date.available2025-07-15T08:41:54Z-
dc.identifier.urihttp://hdl.handle.net/10397/114151-
dc.language.isoenen_US
dc.publisherElsevier Inc.en_US
dc.rightsCrown Copyright ª 2025 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/ by-nc-nd/4.0/).en_US
dc.rightsThe following publication Zhang, X., Wang, S., Huang, Y., Xie, Y., Seth, I., Bulloch, G., Lai, C., Hu, Y., Shang, X., He, M., Zhu, Z., & Yu, H. (2025). Exploring Effects of Age at the Onset of Myopia on Multiple Diseases Using Electronic Health Records. Ophthalmology Science, 5(5), 100819 is available at https://doi.org/10.1016/j.xops.2025.100819.en_US
dc.subjectAge at myopia onseten_US
dc.subjectMendelian randomizationen_US
dc.subjectMyopia-related comorbiditiesen_US
dc.subjectPhenome-wide association studyen_US
dc.titleExploring effects of age at the onset of myopia on multiple diseases using electronic health recordsen_US
dc.typeJournal/Magazine Articleen_US
dc.identifier.spage -
dc.identifier.epage -
dc.identifier.volume5-
dc.identifier.issue5-
dc.identifier.doi10.1016/j.xops.2025.100819-
dcterms.abstractPurpose: To examine whether genetic predisposition to age at the onset of myopia is associated with the development of future diseases.-
dcterms.abstractDesign: Mendelian randomization phenome-wide association study (MR-PheWAS) from the UK Biobank.-
dcterms.abstractParticipants: A polygenic risk score (PRS) for age at the onset of myopia was constructed using 80 variants selected from a genome-wide association study. Participants were eligible if they had available genetic information during recruitment between March 13, 2006, and October 1, 2010. Disease outcomes were mapped to phenotype codes (phecodes) based on hospital episode statistics and causes of death up to April 29, 2021.-
dcterms.abstractMethods: The analysis of phenome-wide association studies (PheWAS) identified possible associations between the age of myopia-onset PRS and a range of disease outcomes. Cox proportional hazards analysis and 2-sample Mendelian randomization (MR) further confirmed associations between PRS and diseases passing Bonferroni correction. The disease-trajectory analysis explored the sequential patterns in childhood-onset and adult-onset groups.-
dcterms.abstractMain Outcome Measures: Disease outcomes related to age at the onset of myopia.-
dcterms.abstractResults: Our study population comprised 315 568 UK Biobank participants, and 1000 unique phecodes from 17 different disease categories were included for analysis. After Bonferroni correction, PheWAS identified younger age at myopia-onset PRS was associated with hospital-diagnosed myopia and 13 other outcomes when using the Bonferroni threshold (all P < 5.0 × 10−5). Eleven distinct disease associations with dose-response effects were confirmed using Cox proportional hazards analysis with stratified PRS. Two-sample MR analyses provided further support for the effects of younger age at myopia on higher risks of retinal detachments, cataracts, disorders of the vitreous body, and hypothyroidism, whereas older age of the onset of myopia conferred a higher risk of primary angle-closure glaucoma. Temporal analyses indicated myopia preceded the above disorders in both the childhood-onset and adult-onset groups.-
dcterms.abstractConclusions: This data-driven MR-PheWAS identified a range of ocular disorders and hypothyroidism that were related to age at the onset of myopia. Our results highlight the importance of treating younger-onset myopia and the management of myopia-related comorbidities.-
dcterms.abstractFinancial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.-
dcterms.accessRightsopen accessen_US
dcterms.bibliographicCitationOphthalmology science, Sept-Oct. 2025, v. 5, no. 5, 100819-
dcterms.isPartOfOphthalmology science-
dcterms.issued2025-09-
dc.identifier.scopus2-s2.0-105007452443-
dc.identifier.eissn2666-9145-
dc.identifier.artn100819-
dc.description.validate202507 bcch-
dc.description.oaVersion of Recorden_US
dc.identifier.FolderNumbera3849een_US
dc.identifier.SubFormID51401en_US
dc.description.fundingSourceOthersen_US
dc.description.fundingTextNational Natural Science Foundation of Chinaen_US
dc.description.fundingTextChina Postdoctoral Science Foundationen_US
dc.description.fundingTextGuangdong Basic and Applied Basic Research Foundationen_US
dc.description.fundingTextBrolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients with Persistent Diabetic Macular Edemaen_US
dc.description.fundingTexte launch fund of Guangdong Provincial People’s Hospital for NSFCen_US
dc.description.pubStatusPublisheden_US
dc.date.embargo en_US
dc.description.oaCategoryCCen_US
Appears in Collections:Journal/Magazine Article
Files in This Item:
File Description SizeFormat 
1-s2.0-S2666914525001174-main.pdf1.86 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show simple item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.